| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 04/26/2011 | CA2446619C Permeation enhancers |
| 04/26/2011 | CA2446461C Substituted cyclohexane-1,4-diamine derivatives |
| 04/26/2011 | CA2446112C A method for regulating immune function in primates using the foxp3 protein |
| 04/26/2011 | CA2428785C Nanoparticulate compositions comprising a drug and copolymers of vinyl pyrrolidone and vinyl acetate as surface stabilizers |
| 04/26/2011 | CA2420231C Antibodies to human il-1.beta. |
| 04/26/2011 | CA2415397C Use of strains of parapoxvirus ovis for producing antiviral medicaments and medicaments against cancer |
| 04/26/2011 | CA2408838C Drug/drug delivery systems for the prevention and treatment of vascular disease |
| 04/26/2011 | CA2376064C Factor viia inhibitors |
| 04/26/2011 | CA2319093C Sea cucumber carotenoid lipid fraction products and methods of use |
| 04/26/2011 | CA2264012C Compositions and methods for polynucleotide delivery |
| 04/26/2011 | CA2215394C Il-17 receptor |
| 04/26/2011 | CA2201482C Novel ectoparasite saliva proteins and apparatus to collect such proteins |
| 04/21/2011 | WO2011047384A2 Methods of inhibiting ire1 |
| 04/21/2011 | WO2011047173A2 Pharmaceutical compositions for oral administration |
| 04/21/2011 | WO2011047055A2 Novel mek inhibitors, useful in the treatment of diseases |
| 04/21/2011 | WO2011047040A2 Methods and compositions to support transplanted tissue integration and innosculation with adipose stromal cells |
| 04/21/2011 | WO2011046970A1 Amino - pyrimidine compounds as inhibitors of tbkl and/or ikk epsilon |
| 04/21/2011 | WO2011046381A2 COMPOSITION FOR INHIBITING TGF-β COMPRISING IMIDAZOPURINE DERIVATIVES |
| 04/21/2011 | WO2011046200A1 Antiinflammatory agent comprising differentiation-inducing factor or analog thereof |
| 04/21/2011 | WO2011045594A1 Novel macrocycles and methods for their production |
| 04/21/2011 | WO2011045593A1 Novel macrocyles and methods for their production |
| 04/21/2011 | WO2011045075A1 Compositions comprising tramadol and celecoxib in the treatment of pain |
| 04/21/2011 | WO2011044962A1 Co-crystals of tramadol and coxibs |
| 04/21/2011 | WO2011012896A3 Spirocyclic amide derivatives |
| 04/21/2011 | WO2010144742A3 Co-administration of an agent linked to an internalization peptide with an anti-inflammatory |
| 04/21/2011 | WO2010144721A3 Model systems and treatment regimes for treatment of neurological disease |
| 04/21/2011 | WO2010143075A3 Silver hydrosol, dental applications and other uses thereof |
| 04/21/2011 | WO2010135527A3 Elastin for soft tissue augmentation |
| 04/21/2011 | WO2010067130A8 P38 map kinase inhibitors |
| 04/21/2011 | US20110092669 Synthesis of cyclosporin analogs |
| 04/21/2011 | US20110092603 Composition to enhance the bioavailability of curcumin |
| 04/21/2011 | US20110092599 Use of Treprostinil to treat neuropathic diabetic foot ulcers |
| 04/21/2011 | US20110092598 Driectly Compressible High Functionality Granular Microcrystalline Cellulose Based Excipient, Manufacturing Process and Use Thereof |
| 04/21/2011 | US20110092596 Polymorphs of bromfenac sodium and methods for preparing bromfenac sodium polymorphs |
| 04/21/2011 | US20110092591 Phenyl-prenyl derivatives, of marine and synthetic origin, for the treatment of cognitive, neurodegenerative or neuronal diseases or disorders |
| 04/21/2011 | US20110092589 Treatment of Inflammatory Conditions and Diseases with Metal-Thiols |
| 04/21/2011 | US20110092588 Lactone formulations and method of use |
| 04/21/2011 | US20110092584 Therapeutic use of quinonoid derivatives of cannabinoids |
| 04/21/2011 | US20110092573 Modification of myd88 splicing using modified oligonucleotides |
| 04/21/2011 | US20110092568 Modulation of mlck-l expression and uses thereof |
| 04/21/2011 | US20110092564 Cyclic amino acids for the treatment of pain |
| 04/21/2011 | US20110092561 Benzoisoindole derivatives for the treatment of pain |
| 04/21/2011 | US20110092538 Compounds and methods for kinase modulation, and indications therefor |
| 04/21/2011 | US20110092519 5,7-disubstituted thiazolo[4,5-d]pyrimidines as chemokine inhibitors |
| 04/21/2011 | US20110092517 Use of PPAR Delta Ligands for the Treatment or Prevention of Inflammation or Energy Metabolism/Production Related Diseases |
| 04/21/2011 | US20110092512 New hsl inhibitors useful in the treatment of diabetes |
| 04/21/2011 | US20110092510 Dpp-iv inhibitors for use in the treatment of nafld |
| 04/21/2011 | US20110092506 Trisubstituted amine compound |
| 04/21/2011 | US20110092502 Diaminothiazoles useful as axl inhibitors |
| 04/21/2011 | US20110092501 Novel inhibitors |
| 04/21/2011 | US20110092499 N-containing heterocyclic compounds |
| 04/21/2011 | US20110092478 Diazabenzo[de] anthracen-3-one compounds and methods for inhibiting parp |
| 04/21/2011 | US20110092474 Diamino-pyridine, pyrimidine, and pyrazine modulators of the histamine H4 receptor |
| 04/21/2011 | US20110092447 Using inhibitors of histone deacetylases for the suppression therapy of inherited disease predisposing conditions |
| 04/21/2011 | US20110092438 Composition for external application comprising transcription factor decoy as active ingredient |
| 04/21/2011 | US20110092411 Recombinant lactoferrins, methods of production from plants and uses thereof |
| 04/21/2011 | US20110091920 METHOD OF DIAGNOSING A CLINICAL CONDITION BY DETECTION OF A PAPP-A/proMBP COMPLEX |
| 04/21/2011 | US20110091876 Zcytor19 polynucleotides, polypeptides, antibodies and methods of use |
| 04/21/2011 | US20110091578 Method of stimulating tissue healing |
| 04/21/2011 | US20110091577 Drug release coatings on calcuim phosphate and uses thereof |
| 04/21/2011 | US20110091542 Baclofen and r-baclofen gastroretentive drug delivery systems |
| 04/21/2011 | US20110091538 Polymer adapted to release bioactive agents in vivo, pharmaceutical composition and method of preparation thereof |
| 04/21/2011 | US20110091536 Compositions comprising euphorbia prostrata and process of preparation thereof |
| 04/21/2011 | US20110091535 Solid pharmaceutical formulation |
| 04/21/2011 | US20110091508 Oligofluorinated cross-linked polymers and uses thereof |
| 04/21/2011 | US20110091505 Treatment of Mammalian Physiological Reaction of IgE Antibodies Present in Said Mammal Upon Contact With the Corresponding Antigen |
| 04/21/2011 | US20110091503 Therapeutic composition with a botulinum neurotoxin |
| 04/21/2011 | US20110091485 Modulation of cell junctions |
| 04/21/2011 | US20110091475 Anti-Human Interleukin-20 Antibodies |
| 04/21/2011 | US20110091472 Compositions for treating psoriasis |
| 04/21/2011 | US20110091469 Attractin/mahogany-like polypeptides, polynucleotides, antibodies and methods of use thereof |
| 04/21/2011 | US20110091461 Binding domain-immunoglobulin fusion proteins |
| 04/21/2011 | US20110091459 Imidazole modulators of muscarinic acetylcholine receptor m3 |
| 04/21/2011 | US20110091456 Treatment of neurological conditions |
| 04/21/2011 | US20110091453 Methods of administering/dosing cd2 antagonists for the prevention and treatment of autoimmune disorders or inflammatory diseases |
| 04/21/2011 | US20110091449 Isolation of Anti-Desmoglein 1 Antibodies by Phage Display of Pemphigus Foliaceus Autoantibodies |
| 04/21/2011 | US20110091440 Prophylactic and therapeutic treatment of neuro-degenerative diseases and protein aggregation diseases |
| 04/21/2011 | US20110091437 Fusion proteins |
| 04/21/2011 | US20110091425 Upregulation of opioid receptors for management |
| 04/21/2011 | US20110091422 Use of Genetic Markers for Identifying the Response to Interferon Treatment in Multiple Sclerosis Patients |
| 04/21/2011 | US20110091415 Hydroxyethyl Starch-Containing Polypeptide Compositions |
| 04/21/2011 | US20110091403 Oligosaccharide aldonic acids and their topical use |
| 04/21/2011 | US20110091385 Substituted aryl piperidinylalkynyladenosines as a2ar agonists |
| 04/21/2011 | DE102009049679A1 Pyrazolopyrimidinderivate Pyrazolopyrimidinderivate |
| 04/21/2011 | CA2814617A1 Novel mek inhibitors, useful in the treatment of diseases |
| 04/21/2011 | CA2777823A1 Antibody therapeutics with local activity in the digestive tract |
| 04/21/2011 | CA2777782A1 Sepiapterin reductase inhibitors for the treatment of pain |
| 04/21/2011 | CA2777762A1 Amino - pyrimidine compounds as inhibitors of tbk1 and/or ikk epsilon |
| 04/21/2011 | CA2771665A1 Co-crystals of tramadol and coxibs |
| 04/20/2011 | EP2311872A1 Albumin fusion proteins |
| 04/20/2011 | EP2311869A1 Use of mammalian cytokine; related reagents |
| 04/20/2011 | EP2311867A1 Trimeric binding proteins for trimeric cytokines |
| 04/20/2011 | EP2311864A1 Recombinant protein-s composition |
| 04/20/2011 | EP2311847A1 Composition containing stable vitamin B6 derivative |
| 04/20/2011 | EP2311829A1 Substituted alkylamine derivatives and methods of use |
| 04/20/2011 | EP2311818A1 Combination of a 5-phenylthiazole compound as PI3 kinase inhibitor with an antiinflammatory, bronchodilatory or antihistamine drug |
| 04/20/2011 | EP2311808A1 Substituted alkylamine derivatives and methods of use |
| 04/20/2011 | EP2311806A2 Dihydropyridine-, pyridine-, benzopyranone- and triazoloquinazoline derivatives, their preparation and their use as adenosine receptor antagonists |
| 04/20/2011 | EP2311529A1 Botanical extract composition |
| 04/20/2011 | EP2311485A1 Thymosin beta 4 promotes wound repair |